115 filings
Page 2 of 6
8-K
gi49fyatvl1
9 May 23
Regulation FD Disclosure
9:12am
EFFECT
129j8hq219q0p4j
4 May 23
Notice of effectiveness
12:15am
ARS
yuq9vgxgf 14
1 May 23
Annual report to shareholders
4:41pm
DEFA14A
0btp ivzlb
1 May 23
Additional proxy soliciting materials
4:35pm
CORRESP
e7w0z
1 May 23
Correspondence with SEC
12:00am
UPLOAD
emg ej2xv
24 Apr 23
Letter from SEC
12:00am
8-K
fggk0pgylnv8zbktc
23 Mar 23
ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
4:09pm
8-K
0t2j2uu
13 Mar 23
Regulation FD Disclosure
9:26am
8-K
2jmb9d4
22 Feb 23
Entry into a Material Definitive Agreement
4:11pm
8-K
srx8cp42
14 Feb 23
Results of Operations and Financial Condition
6:12am
8-K/A
ehtub 5xnt
17 Jan 23
Report of Independent Registered Public Accounting Firm
5:06pm
S-8
3eebpxlmezr
17 Jan 23
Registration of securities for employees
4:30pm
8-K
f44dkq aq01xmk72
9 Dec 22
Departure of Directors or Certain Officers
5:02pm
8-K
7ad2jx4
6 Dec 22
Regulation FD Disclosure
5:07pm
8-K
svmg91r 6cxn
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
DEFA14A
k61d4moa
2 Nov 22
Additional proxy soliciting materials
6:09am